about
Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected]Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha.Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatmentsLeishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patientsAntiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major.Visceral leishmaniasis treatment, Italy.The relationship between leishmaniasis and AIDS: the second 10 yearsNeglected tropical diseases: survey and geometry of randomised evidence.Developments in the treatment of leishmaniasis and trypanosomiasis.First case of typical Old World cutaneous leishmaniasis treated with miltefosine.Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.In vivo efficacy of gum obtained pistacia atlantica in experimental treatment of cutaneous leishmaniasis.Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.Association between canine leishmaniosis and Ehrlichia canis co-infection: a prospective case-control study.
P2860
Q28480699-2A0B8D87-6EA9-40E0-826E-E95455CFCE74Q33452545-4F27C16C-EF03-463E-94D9-6C6FCFD1454EQ33978764-9D256F63-F701-402C-B772-3E679891DECBQ34138468-4327DDEB-B791-4DBB-B0AF-F5FA62497B8DQ34229670-F0388EE8-2241-4561-92C6-301FEE66FB78Q34437935-321675A8-A8A9-40D5-BEAC-C9A64A4EB236Q34545589-5B26D6C7-7246-42C5-9799-87A73ED464A9Q34554991-08620628-8262-4650-BC37-4292EB8105DDQ36538814-E4360BEE-BD23-439A-A503-3A7E84E31255Q38054293-E78038BF-79DB-42C5-BA61-3B215ACF035FQ39322841-D8950481-DC92-4278-BC86-CAEAD4E76E02Q39492098-93035B15-5DDE-430A-A51A-23E60E9FBC94Q41603970-0ECA8230-97DB-43E8-88ED-8D336CB6FA84Q42072580-0338613E-E90A-465C-972B-7CB5CE655768Q42429900-F9E56D4E-1E7F-44C4-9378-31C95147B652Q43290047-BB806CFF-1F66-4F39-B8A3-FC819CA3868AQ43863718-9CB929E3-8BFE-49C1-BD05-ED6FDCFCB9FFQ44215050-BD5DD353-448E-4B1B-A5A8-32C9CA3D4711Q44895818-A99648A2-56B9-44CE-8AD6-A39DC2EF9194Q51767677-718CE2FE-4AF6-4840-91BE-86DA089458F8Q52382222-5705DAB7-8CF2-43E2-B408-8BC5FCC18191
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Practical guide for the treatment of leishmaniasis.
@en
type
label
Practical guide for the treatment of leishmaniasis.
@en
prefLabel
Practical guide for the treatment of leishmaniasis.
@en
P1433
P1476
Practical guide for the treatment of leishmaniasis.
@en
P2093
Davidson RN
P304
P356
10.2165/00003495-199856060-00005
P577
1998-12-01T00:00:00Z
P6179
1033911128